Carbon monoxide effects on human ventricle action potential assessed by mathematical simulations by Trénor Gomis, Beatriz Ana et al.
ORIGINAL RESEARCH ARTICLE
published: 17 October 2013
doi: 10.3389/fphys.2013.00282
Carbon monoxide effects on human ventricle action
potential assessed by mathematical simulations
Beatriz Trenor1, Karen Cardona1, Javier Saiz1, Sridharan Rajamani2, Luiz Belardinelli 2 and
Wayne R. Giles3*
1 Instituto Interuniversitario de Investigación en Bioingeniería y Tecnología Orientada al Ser Humano, Universitat Politècnica de València, Valencia, Spain
2 Cardiovascular Therapeutic Area, Gilead Sciences, Foster City, CA, USA
3 Faculty of Kinesiology, University of Calgary, Calgary, AB, Canada
Edited by:
Christopher Huang, University of
Cambridge, UK
Reviewed by:
Gareth D. K. Matthews, University
of Cambridge, UK
Christopher Huang, University of
Cambridge, UK
*Correspondence:
Wayne R. Giles, Faculty of
Kinesiology, University of Calgary,
2500 University Drive, Calgary AB
T2N 1N4, Canada
e-mail: wgiles@ucalgary.ca
Carbon monoxide (CO) that is produced in a number of different mammalian tissues is
now known to have significant effects on the cardiovascular system. These include: (i)
vasodilation, (ii) changes in heart rate and strength of contractions, and (iii) modulation
of autonomic nervous system input to both the primary pacemaker and the working
myocardium. Excessive CO in the environment is toxic and can initiate or mediate life
threatening cardiac rhythm disturbances. Recent reports link these ventricular arrhythmias
to an increase in the slowly inactivating, or “late” component of the Na+ current in
the mammalian heart. The main goal of this paper is to explore the basis of this
pro-arrhythmic capability of CO by incorporating changes in CO-induced ion channel
activity with intracellular signaling pathways in the mammalian heart. To do this, a quite
well-documented mathematical model of the action potential and intracellular calcium
transient in the human ventricular myocyte has been employed. In silico iterations based
on this model provide a useful first step in illustrating the cellular electrophysiological
consequences of CO that have been reported from mammalian heart experiments.
Specifically, when the Grandi et al. model of the human ventricular action potential is
utilized, and after the Na+ and Ca2+ currents in a single myocyte are modified based on
the experimental literature, early after-depolarization (EAD) rhythm disturbances appear,
and important elements of the underlying causes of these EADs are revealed/illustrated.
Our modified mathematical model of the human ventricular action potential also provides
a convenient digital platform for designing future experimental work and relating these
changes in cellular cardiac electrophysiology to emerging clinical and epidemiological data
on CO toxicity.
Keywords: carbon monoxide (CO), late sodium current (INa-L), action potential (AP), early after-depolarizations
(EADs), S-nitrosylation
INTRODUCTION
It is now well known that carbon monoxide (CO) has significant
physiological and pathophysiological effects in a number of dif-
ferent organ systems in mammals (Wu and Wang, 2005). This
paper considers CO induced ventricular rhythm disturbances
in the human heart. Recently, attention has been drawn to the
fact that CO can induce cardiac arrhythmias. This is based on
a number of studies in animal models and literature regarding
emergency hospital admissions due to life-threatening cardiac
rhythm disturbances triggered by increases in ambient levels of
CO (Goldstein, 2008; Bell et al., 2009; Dallas et al., 2012). More
generally, substances somewhat similar to CO, including nitric
oxide (NO), and hydrogen sulfide (H2S) are now often referred
to in the neurophysiological literature as gaseous transmitters
(Leffler et al., 2006). These compounds are receiving increased
attention as (i) mediators or modulators of significant, some-
times acute pathophysiological challenges, and as (ii) potential
targets for therapeutic interventions (Motterlini and Otterbein,
2010).
The ability of CO to alter electrophysiological activity in the
heart and nervous system has led to quite broad-ranging exam-
inations of the ability of CO to regulate specific ion channels
(Wilkinson and Kemp, 2011). These effects can occur either as
direct actions of CO, or (and more commonly) CO effects on
closely related intracellular signaling pathways, often involving
nitric oxide signaling, metabolism, and/or downstream targets for
chemical modifications of individual amino acids in functional
proteins. In the cardiovascular system, specific attention has been
drawn to S-nitrosylation of, specific ion channel residues (Jaffrey
et al., 2001; Haldar and Stamler, 2013).
In this paper, our focus will be on the cellular electrophysio-
logical effects of NO and related S-nitrosylation of specific sites
on ion channels, ion transporters, or directly related signaling
molecules (Jaffrey et al., 2001; Tamargo et al., 2010; Haldar and
Stamler, 2013). This is because many cellular effects initiated
by increased CO levels are mediated by downstream changes in
NO and ultimately through targeted nitrosylation of defined sites
(residues). At present, it is known that NO/S-nitrosylation can:
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(i) increase the background K+ current that generates the resting
potential in heart (Gómez et al., 2009) (ii) activate ATP sensitive
K+ channels in neurons (Kawano et al., 2009), and (iii) reduce a
major repolarizing current (Kv1.5) in mammalian atria (Núñez
et al., 2006). In addition, a similar CO and/or NO induced reac-
tion mechanism, as S-nitrosylation, can modulate (iv) Na+/K+
ATPase turn over in the hypoxic heart (Yakushev et al., 2012), and
(v) alter release of Ca2+ from the sarcoplasmic reticulum (SR)
by targeting the ryanodine receptor complex in heart and skele-
tal membranes (Gonzalez et al., 2010; Wang et al., 2010). There
is also evidence that NO can increase the slowly inactivating or
late Na+ current in nerve, muscle and heart preparations (Ahern
et al., 2000; Evans and Bielefeldt, 2000).
Two recent papers (Abramochkin et al., 2011; Dallas et al.,
2012) have reported CO induced changes in electrical activity
and contractions, as well as induction of cardiac arrhythmias
in a rat ventricle model. Evidence that a major ion channel
mediated effect is an augmentation of slow inactivation of the
cardiac Na+ current is provided. These results also emphasize an
essential involvement of NO as a second messenger of this CO-
induced effect. CO-induced increases in this late Na+ current,
INa−L, can significantly lengthen the action potential (AP) and
result in abnormal electrical activity (early after-depolarization,
EADs) characterized by repetitive firing, even after application of
only one stimulus (Dallas et al., 2012). This arrhythmia can be
reduced substantially following superfusion of this experimental
preparation with the compound ranolazine (Dallas et al., 2012).
Ranolazine, originally developed as a coronary vasodilator, is now
known to be a potent and quite selective inhibitor of the INa-L in
a number of different mammalian preparations (Makielski and
Valdivia, 2006; Zaza et al., 2008), and also in human ventricle
(Moss et al., 2008). Ranolazine effects are significant in the set-
tings of stable angina and also in heart failure where, in both cases,
it is known that INa-L is increased (c.f. Trenor et al., 2012).
The main goal of our mathematical simulations is to illustrate,
using a current mathematical model of the AP in human ven-
tricle, the consequences of a CO induced: (i) increase in INa-L,
(ii) NO-S-nitrosylation induced changes in ICa-L, and (iii) this
combination. For this purpose, CO-induced changes in INa-L that
are similar to those reported in the primary experimental data
(Dallas et al., 2012) were introduced into two different mod-
els of the ventricular AP and the consequences were explored
systematically.
METHODS
HUMAN VENTRICULAR MYOCYTE MODELS
To simulate the electrical activity of human ventricular myocytes,
two relatively recent AP models were evaluated. The Grandi et al.
model (Grandi et al., 2010) is perhaps the most detailed math-
ematical model that is available, when judged in terms of its
comprehensive ionic current portfolio and inclusion of mathe-
matical expressions for the Ca2+ transient and Ca2+ homeostasis
in the human ventricle. For the purpose of simulating some
aspects of heart failure we have previously modified and utilized
the original Grandi et al. model (Trenor et al., 2012). In this paper,
the slowly inactivating component of INa, which is denoted INa-L,
was reformulated based on experimental data. In the simulations
presented here, we have made use of this code: specifically the
Grandi model was employed after (i) modifying the Na+ current
as in (Trenor et al., 2012), (ii) changing the L-type Ca2+ current,
ICa-L, or (iii) both.
Early in this study, some simulations were carried out using
the latest human ventricular AP model published by O’Hara et al.
(2011). This model is based on experimental data taken from 140
healthy human hearts; it encompasses the formulation of 18 ionic
currents and carrier-mediated fluxes and a detailed formulation
of steady-state and transient ion concentrations, including intra-
cellular Ca2+ transients. This model reproduces many aspects of
the electrophysiological behavior of human ventricular myocytes
with high fidelity, and can simulate some AP alterations due to
drug effects. However, it appears not to be able to generate/exhibit
any EADs in response to the reported, CO induced, changes
in INa or ICa or their combination. We have not explored the
reasons for this in detail; however, it is likely that the net cur-
rent at the level of the plateau of the AP is an area for further
examination/modification.
SIMULATION OF CO EFFECTS
As reported in (Dallas et al., 2012), CO can reduce peak tran-
sient inward INa by as much as 50%, shift the inactivation curve
in hyperpolarizing direction, and significantly increase the late
sodium current INa-L. Thus, in our simulation CO effects on
the fast component of INa were modeled by introducing a 50%
decrease in INa maximum conductance and a 5mV shift in the
hyperpolarizing direction of the two Na+ current inactivation
relationships h∞ and j∞ (see Equation 1). In addition, INa-L was
increased 2-fold compared to its values in the original Grandi
et al. model (Trenor et al., 2012).
h∞_shifted = j∞_shifted = 1(
1 + e Vm + 71.55+ 57.43
)2 (1)
Vm is the membrane potential.
CO is known to elevate NO levels (Dallas et al., 2012), and this
“second messenger” can have important effects on L-type Ca2+
current, ICa-L, in the mammalian (ferret) heart, as documented
in the detailed studies of Campbell et al. (1996). These investi-
gators reported a significant increase in ICa-L (30–50%) under
conditions of NO induced S-nitrosylation of this Ca2+ channel
α-subunit. In addition, this paper also reported a nitrosylation
induced change in ICa-L gating—specifically a small but signifi-
cant change in the voltage dependent activation relationship—an
approximately 6.5mV shift in the hyperpolarizing direction. To
reproduce these effects using the Grandi et al. model (Grandi
et al., 2010), we have made a number of changes in these param-
eters. The most favorable/realistic results were obtained when the
maximum conductance for ICa-L was increased by 20% and its
activation gate was shifted 3mV in the hyperpolarizing direction
(see Equation 2). The changes applied were slightly smaller than
the ones reported experimentally, but were sufficient to trigger
EADs, as shown in Figure 2.
d∞_shifted = 1
1 + e Vm + 5+ 36
(2)
Vm is the membrane potential.
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SIMULATION OF RANOLAZINE EFFECTS
The effects of ranolazine, at an assumed plasma level of 5–10μM,
were simulated by decreasing the maximum INa-L conductance by
50% (see Figure 4) (cf. Trenor et al., 2013). This maneuver was
based on the fact that the recommended adult dosage level for
ranolazine is in the 3–8μM range (Belardinelli et al., 2006).
STIMULATION PROTOCOLS
AP simulations were conducted at a stimulation rate of 1Hz.
Measurements were taken on stimulated output data only after
achieving steady-state conditions.
NUMERICAL IMPLEMENTATION
All model equations were taken from Grandi et al. (2010), and
were implemented in Matlab (Mathworks Inc., Natick, MA,
USA). Differential equations were solved numerically using a
variable order solver (ode15s) (Shampine and Reichelt, 1997).
As indicated, some simulations were performed using O’Hara
et al. model, which was also implemented inMatlab. These model
equations were downloaded from http://rudylab.wustl.edu, and
the rapid integration methods provided in the Supplemental
Materials from O’Hara et al. (2011) and one of our previous
papers (Trenor et al., 2012) were used.
RESULTS
The initial set of computations was done for the purpose of
illustrating the consequences of the CO induced changes in mam-
malian heart Na+ current, INa that were described in a primary
experimental study. This paper (Dallas et al., 2012) reported that
CO acting through an intracellular NO-mediated signaling cas-
cade can (i) reduce peak INa by as much as 50% while also (ii)
shifting the inactivation curve for the large transient compo-
nent of INa in hyperpolarizing direction, and (iii) significantly
increasing the slowly inactivating component of INa (which is
denoted INa-L).
The two superimposed human ventricular APs in Figure 1A
illustrate the control AP waveform at 1Hz, and the AP elicited
following the changes in INa and INa-L described above. For these
computations, the steady-state inactivation curve was shifted in
the hyperpolarizing direction by 5mV and INa-L was increased
2-fold. Figure 1B shows the changes in INa-L; Figure 1C illustrates
the indirect effects on ICa-L; that is, the AP waveform lengthened,
and this changed the ICa-L; and Figure 1D shows the computed
intracellular Ca2+ transient, [Ca2+]i.
In summary the reported changes in INa and INa-L, when
combined, result in predictable decreases in AP rate-of-rise
(not shown) and small increase in AP duration. However,
these changes fail to elicit spontaneous firing (EADs on DADs)
or produce any correlates of arrythmogenesis. Although this
pattern of results was somewhat unexpected, it is impor-
tant to recall that the primary experimental data on CO
were obtained in rat hearts (Ahern et al., 2000; Dallas et al.,
2012), and not from human ventricular tissue or myocytes.
We therefore, continued to attempt to illustrate and fur-
ther understand the electrophysiological effects of CO on
the human ventricular myocardium by considering additional
variables.
FIGURE 1 | Effects of carbon monoxide (CO) induced changes in Na+
current on the action potential in a human ventricular myocyte. In this
and all subsequent Figures, the Grandi et al. mathematical model of the
human ventricular action potential was employed (see Methods). Control
simulations are shown as black traces and simulations generated by
selected changes in model parameters are shown in red. Panel (A) consists
of control action potentials (black, 1Hz., steady state) together with
superimposed action potentials (red) that were elicited by the same
stimulus parameters after: (i) reducing peak Na+ current by 50%, (ii) shifting
the steady state inactivation relationship 5mV in the hyperpolarizing
direction, and (iii) altering the mathematical descriptors that govern the
slowly inactivating or late sodium current, INa-L, such that its size was
increased 2-fold. As expected, these changes reduced excitability and
decreased the dV/dt of the action potential upstroke as well as lengthening
the AP at both APD-30 and APD-90. INa-L records are shown in Panel (B). In
Panels (C,D) the corresponding L-type Ca2+ current, ICa-L, and intracellular
calcium transient, [Ca2+]i are illustrated. Note that these changes are
indirect, i.e., they result from the changes in APD waveform and the
intrinsic biophysical properties of ICa-L and the Ca2+-induced Ca2+ release
(CICR) mechanisms.
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In fact, studies of NO-mediated effects in heterologous expres-
sion systems utilizing the alpha subunit of the human heart Na+
channel, Nav1.5 (Ueda et al., 2008), reveal a somewhat differ-
ent pattern of results. These include (i) an (approximately 30%)
increase in peak inward Na+ current, a (ii) small hyperpolarizing
shift in the steady-state inactivation curve for INa, (iii) a marked
enhancement (approximately 2-fold) in INa-L and (iv) an essential
NO-induced S-nitrosylation of a defined residue onNav1.5. These
changes, when introduced into the Grandi model, also failed to
result in increased arrhythmogenesis (results not shown).
We were aware of the detailed studies of Campbell et al.
(1996) on the effects of NO on ICa-L, in the mammalian (fer-
ret) heart. These investigators reported a significant increase in
ICa-L (30–50%) under conditions of NO induced S-nitrosylation
of this Ca2+ channel α-subunit. Importantly, this paper also
reported a nitrosylation-induced change in ICa-L gating, specifi-
cally, a small but significant shift in the voltage dependent acti-
vation relationship—approximately 6mV in the hyperpolarizing
direction. The superimposed APs in Figure 2 illustrate the con-
sequences of introducing these changes into the original Grandi
et al. model (Grandi et al., 2010). Panel (A) shows the AP wave-
forms (black, baseline, or control) (red, following ICa-L changes).
INa-L and ICa-L records are shown in Panels (B,C), respectively.
The L-type Ca2+ current is shown in Panel (C). As shown in
Panel (D), these changes in ICa-L also resulted in a large increase
in [Ca2+]i, and the [Ca2+]i exhibited pronounced frequency
dependence or alternans (see Discussion and Clark et al., 1996;
Bouchard et al., 2004).
Detailed inspection of Figure 2 and comparison of this pattern
of results with those in Figure 1 reveal (Panel B) that INa-L now
shows pronounced changes in peak amplitude, even in response
to the fixed stimulus rate at 1Hz. Presumably, this arises from
the markedly prolonged AP and intrinsic voltage-dependence of
reactivation of INa-L (see Discussion).
The third set of computations in this study combined the
reported CO induced changes in INa and INa-L (Figure 1), with
those for ICa-L (Figure 2). The resulting very significant changes
in AP duration (Panel A), INa-L (Panel B), ICa-L (Panel C), and
[Ca2+]i (Panel D) are shown in Figure 3. This pattern of results
was similar to, but not identical with Figure 2. In particular, the
majority of the APs elicited at a physiological stimulus rate (1Hz)
exhibited marked prolongation (approximately 100%), with the
appearance of an EAD late in the prolonged plateau phase. Note
that under these starting conditions, the combined inward cur-
rents due to INa-L and ICa-L “held” the membrane potential of the
plateau near 0mV in contrast with the approximately −10mV
plateau level in Figure 2.
The pattern of changes shown in Figure 3 is not surprising. It
is nowwell known that abnormal, slow depolarizations, which are
denoted EADs, can be elicited by changes in ICa-L (Marban et al.,
1986; January and Riddle, 1989, for review see Clusin, 2003). In
fact, in rabbit ventricle a recent report from the Weiss laboratory
(Madhvani et al., 2011) has illustrated in detail ways in which even
very small changes in the voltage dependence of the activation of
ICa-L can give rise to EADs. This is mainly, but not entirely due
to the fact that there is an increased inward current at or very
FIGURE 2 | Effects of CO-induced changes in L-type Ca2+ current on
the human ventricular myocyte. Based on the work of Campbell et al.,
ICa-L was increased 50% and the voltage dependence for the activation
curve was shifted in the depolarizing direction by 3mV. As shown in Panel
(A) these changes resulted in a lengthening of the action potential plateau
and appearance of associated oscillatory potentials or early after
depolarizations (EADs). Panel (B) shows the changes in INa-L. The longer
APD results in a protracted INa-L; the alterations in amplitude of this
current are due to the voltage dependence of its reactivation. As shown in
Panel (C), these changes in the biophysical parameters that regulate ICa-L
resulted in a change in peak amplitude and perhaps more importantly a
significant alteration in its time course of inactivation. ICa-L also reactivates
under these conditions. Panel (D) shows the control Ca2+ transient and
the computed changes in [Ca2+]i that occur as a consequence of
alterations in the ICa-L.
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FIGURE 3 | Changes in the human ventricular action potential as a
consequence of CO-induced changes in both INa and ICa-L. The layout
and color-coding of this Figure is identical to that described for
Figures 1, 2. As shown in Panel (A) when the CO-induced changes in
Na+ and Ca2+ currents are combined there is marked lengthening of the
action potential and a significantly increased incidence and frequency of
EADs occurring during the somewhat depolarized plateau phase of the
action potential. INa-L records are shown in Panel (B). Panels (C,D) show
the changes in ICa-L and [Ca2+]i . Note that the changes in ICa-L differ
from those in Figure 2 as a result of the alterations in action potential
waveform caused by the combined changes in INa and ICa-L.
FIGURE 4 | Estimation and illustration of the effects of ranolazine on
CO-induced changes in the action potential and underlying INa−L,
ICa-L, and Na+/Ca2+ exchange currents (INCX) in human ventricle. The
effects of ranolazine (shown in black) were modeled as a selective 50%
reduction in the INa-L. Note that this reduces action potential, duration of
every 3rd action potential, as well as decreasing the incidence and the
frequency of EADs. However, these changes are complex. APD (Panel A)
as well as [Ca2+]i and INCX records all show variations or alternans, even
at this fixed stimulus rate (1Hz). Panel (C) illustrates the corresponding
ranolazine-induced changes in the INCX. Note that in the action potential
traces showing a ranolazine-induced shortening of APD, there is no
spontaneous inward INCX current (see also Figure 5 and Results). The
arrows denote the “extra” EADs (Panel A), and underlying [Ca2+]i
transient (Panel B), and INCX (Panel C) records.
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near the range of membrane potentials of the plateau of the nor-
mal or prolonged AP. The underlying biophysical mechanism(s)
involves the non-linear interactions of the small overlapping Ca2+
channel—and Na+/Ca2+—exchanger mediated currents in this
range of membrane potentials (Madhvani et al., 2011, for review
see Fink et al., 2006). The altered AP waveform and related pro-
or anti-arrhythmic effects are sometimes described in terms of
an altered “repolarization reserve” at defined time-points of early
or late repolarization (Wu et al., 2009; Varró and Baczkó, 2011;
Trenor et al., 2013).
If environmental or tissue-derived CO can induce life-
threatening ventricular rhythm disturbances through a mech-
anism involving enhancement of INa-L, it is plausible that, as
mentioned in the Introduction, ranolazine could be effective in
Critical Care settings (Dallas et al., 2012, cf. Belardinelli et al.,
2006; Bell et al., 2009). The mathematical simulations shown
in Figure 4 address this possibility by illustrating the effects of
ranolazine “in silico.” These computations were carried out under
starting conditions (i.e., an initial parameter set) almost identi-
cal to those for Figure 3. However, for these computations it was
assumed that ranolazine actions would be the equivalent of a 50%
reduction of the CO induced increase in INa-L (see Figure 1). The
results show that if ranolazine (at an assumed plasma level of
5μM) did block approximately 50% of INa-L, it could shorten the
AP elicited by a 1Hz train of stimuli. Note, however, that this par-
tial block of INa-L reduced APD only (approximately) every 3rd
AP in this 1Hz AP train. An additional effect is also apparent:
reducing INa-L changes the (i) waveform and (ii) themost negative
membrane potential in some repolarizing components within this
train of AP’s. This primary “effect” appears to be linked function-
ally to the approximately normal repolarization of the next AP.
In summary, when ranolazine is introduced in silico, the result-
ing AP waveforms show complex alternating patterns. However,
there is an increased number of (i) near normal AP waveforms
and (ii) monotonic [Ca2+]i records. The incidence of EADs is also
reduced, consistent with the previously described actions of this
drug in the settings of free radical challenge, genetic abnormali-
ties in Na+ channel biophysics, hypoxia, or global ischemia/heart
failure (Fink et al., 2006; Trenor et al., 2012).
The simulations in Figure 5 address and attempt to illustrate
some of the underlying causative factors for EAD generation
within the framework/limitations of this model of the human
ventricle AP. EAD generation requires the membrane poten-
tial to be relatively depolarized, so that L-type Ca2+ channels
can be activated and contribute a small but significant inward
Ca2+ current. We note that the main interacting (or overlap-
ping) ion channel mediated currents at the plateau of the AP are:
(i) INa-L, (ii) ICa-L, (iii) IK1, a time-independent or background
inwardly rectifying current, and (iv) the delayed rectifier K+ cur-
rent, IK−R (Trenor et al., 2013). In the presence of an enhanced
INa-L the AP plateau is somewhat depolarized and the AP tends
to be prolonged. In addition, under these conditions INCX gener-
ated by the Na+/Ca2+ exchange mechanism can be functionally
important. A key question is: are the pronounced changes in
[Ca2+]i the cause or the consequence of the EAD/CO-induced
pro-arrhythmic substrate. A plausible answer can be obtained by
consideration of the results in Panels (A–F) of Figure 5.
Panel (A) shows two superimposed pairs of APs, each elicited
at steady state (1Hz) before (black) and after (red) introducing
the changes shown in Figure 3. Panels (B,C) show the corre-
sponding INa-L and ICa-L records. Although this information
is redundant with that in Figure 3: here, it provides a means
for direct comparison with the new data: Panel (D), [Ca2+]i
records; Panel (E), INCX; and Panel (F), the Ca2+ content of
the SR.
Taken together, these results suggest that in this model the
CO/NO-induced changes in ICa-L are critical. With each stim-
ulus, a large “extra” Ca2+ influx prolongs the plateau and
results in enhanced Ca2+ release and a much larger increase in
[Ca2+]i. This change in [Ca2+]i can stimulate the INCX. Perhaps
more importantly, however, this time-dependent and cumula-
tive change in myocyte Ca2+ homeostasis results in markedly
increased Ca2+ in the SR. Eventually, this causes anomalous Ca2+
release from the SR, and the Na+/Ca2+ exchanger (denoted by
arrows) responds by generating an inward current that gives rise
to the EAD. Under these conditions, approximately every sec-
ond AP is associated with spontaneous release at the steady-state
stimulus rate of 1Hz.
This scheme/scenario seems plausible, since similar patterns of
changes have been described experimentally. However, it may not
be readily apparent how ranolazine, acting only on INa-L could
be anti-arrhythmic (see Discussion). In brief, the answer appears
to be that ranolazine, by blocking INa-L, can shorten the AP. This
reduction in APD results in reduced Ca2+ influx through ICa-L
during each AP and thus, there is less Ca2+-loading of the SR.
The end result is that SR Ca2+ content does not reach the abnor-
mal levels required for anomalous and spontaneous Ca2+ release.
Hence, there is no intracellular Ca2+ “trigger” for the electro-
genic INCX, that has an important role in initiating the EAD in
this model (Houser, 2000; Clusin, 2003).
DISCUSSION
SUMMARY OF MAIN FINDINGS
Our mathematical modeling illustrates one set of conditions
under which human ventricle myocytes can respond to a sig-
nificant CO induced challenge (environmental or intrinsic) by
generating an aberrant cellular electrophysiological pattern of
responses, denoted EADs.
When using a modified Grandi et al. modeling framework
(Grandi et al., 2010), the reported (Dallas et al., 2012) changes
in Na+ current following CO exposure were not sufficient to pro-
vide the required pro-arrhythmic substrate. Additional changes
in INa-L parameters may have given rise to EAD waveforms.
However, we evaluated the possibility that other ion channel
targets were involved in EAD initiation. Accordingly, our analy-
ses of CO-induced EADs include changes in INa-L and ICa-L. As
shown in Figure 2, even very small changes in ICa-L can produce
EAD generation. Although this pattern of results has not been
reported when CO is used as the “toxic” stimulus; it is known
that NO is a primary mediator of CO-induced pro-arrhythmic
events in the heart (Dallas et al., 2012). Campbell et al. (1996)
have established that NO driven S-nitrosylation can modify ICa-L.
We adopted this approach and were guided by this comprehensive
biophysical/molecular pharmacological data set.
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FIGURE 5 | Diagram illustrating a plausible mechanism for generation
of EADs in our modified Grandi model of the human ventricular
action potential. Panels (A through C) each consist of a pair of
superimposed records for the AP, INa-L, and ICa-L records, respectively.
Those in black correspond to control or baseline conditions, and the
CO-induced changes are shown in red. Important new information is
illustrated in the corresponding (i) INCX currents, Panel (D); (ii) [Ca2+]I data,
Panel (E); and the current generated by Ca2+ release from the
sarcoplasmic reticulum Irel, Panel (F). The arrows denote the EAD
(Panel A) and underlying spontaneous Ca2+ release from the SR (Panel F),
and INCX current driven by the increase in [Ca2+]i (Panel E). Refer to
Results and Discussion sections for further details and explanation.
It is interesting that in spite of an apparent “double hit” being
required for the initiation of EADs, in silico, reduction of only one
of these contributing factors, a 50% decrease of INa-L, resulted in a
reduction in the EAD incidence (see Figure 4). This is consistent
with the experimental observation that selective pharmacological
inhibition of INa-L can serve as an antidote to CO-induced rhythm
disturbances in rat ventricle (Dallas et al., 2012).
MECHANISTIC INSIGHTS
Some aspects of the cellular/biophysical mechanism(s) respon-
sible for EAD generation can be deduced/confirmed by careful
inspection of the new data from our simulations. EADs are
slow, small depolarizations that arise in the ventricle (and in
Purkinje tissue) within a transmembrane voltage range corre-
sponding to the plateau of the ventricular AP (approximately−10
to +10mV). A net inward current is required, and the work
from the Marban (Marban et al., 1986) and January (January
and Riddle, 1989) Laboratories has established that there is an
obligatory requirement for activation of ICa-L. In fact, ICa-L, in
most cases, must reactivate. That is, a small fraction of the same
ICa-L channels that have opened previously in the AP to pro-
duce the distinctive plateau of the human ventricular AP open
again. This produces a “pedestal” or apparently non-inactivating
ICa-L component (Corrias et al., 2011). Our simulations are
interesting in this regard. Detailed inspection of Figures 2–4
in fact show that EAD generation in this model occurs at a
time when the ICa-L pedestal shows a small, transient decrease.
In the Grandi et al. model, this is due to the specific math-
ematical expression of [Ca2+]i dependent inactivation that is
employed.
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However, the non-inactivating component of ICa-L and the
inward current due to INa-L markedly prolong the AP, and this
change in APD waveform results in a significant increase in Ca2+
influx since ICa-L does not fully inactivate. This extra Ca2+ influx,
results in a time-dependent and marked increase in SR Ca2+
content. Eventually this causes a spontaneous and intermittent
(anomalous) pattern of SR Ca2+ release. Each of these increases in
[Ca2+]i gives rise to a significant “new” inward current generated
by the sarcolemmal Na+/Ca2+ exchanger mechanism.
It is worth noting that during CO challenge (intoxication and
recovery) or in any setting involving stress, the known effects of
stimulation of the sympathetic nervous system would be expected
to augment both Na+ and Ca2+ currents. These changes, alone or
in combination, would enhance ICa-L and perhaps INa-L, both of
which would contribute a net inward current at the plateau level
of the ventricular AP. The Koren Laboratory (Liu et al., 2012) has
recently developed a robust model of EAD induced arrhythmias
based on genetically targeted malfunction of distinct repolarizing
K+ currents in adult rabbit ventricle. Their findings provide inter-
esting insights into underlying mechanisms of pro-arrhythmic
impulse generation at relatively depolarized (AP plateau) levels
in the ventricular myocardium. Specifically, they have reported
enhanced EAD activity either (i) following augmentation of ICa-L
with isoproterenol, or (ii) a reduction of repolarizing K+ cur-
rent(s) during hypokalemic conditions. Both of these maneuvers
can alter the net current at the plateau of the AP and thus,
change the repolarization reserve during the early repolariza-
tion phase of the AP (cf. Fink et al., 2006; Sarkar and Sobie,
2011; Trenor et al., 2012). Further insights into the ionic mech-
anisms responsible for EAD initiation and maintenance requires
definition of, and agreement on, the range of membrane poten-
tials at which those small oscillating events occur (Gaur et al.,
2009).
FUTURE DIRECTIONS
As indicated in the Introduction, there are a number of additional
targets or sites, at which CO or CO-generated signaling molecules
are known to act. Perhaps the most important of these are the K+
currents that are expressed throughout themammalian heart, and
have important roles in setting the resting potential and modu-
lating repolarization. The Tamargo Group (Gómez et al., 2009)
has shown that the K+ conductance which underlies the rest-
ing potential in atrium and ventricle, Kir2.1 or IK1, is a target
for S-nitrosylation. This chemical modification of this current
results in increased IK1. Although IK1 is non-linear, it increases
the repolarization reserve during final repolarization, and may
cause a small (1–3mV) hyperpolarization of the resting potential
(cf. Fink et al., 2006). More detailed studies of CO effects should
include this target of CO-mediated channel effects.
Tamargo et al. (Núñez et al., 2006) have also reported that
a prominent repolarizing current in the atrium of most mam-
malian species, Kv1.5, can be altered by S-nitrosylation. Kv1.5 is
decreased by S-nitrosylation, and this would be pro-arrhythmic.
We note however, that Kv1.5 is a small current in human ventricle
(cf. Fink et al., 2006; Grandi et al., 2010).
As noted in the Introduction, theMakielski Group (Ueda et al.,
2008) has reported that NO and an associated S-nitrosylation
modification of INa can result in a significantly enhanced INa-L.
In fact, however, their investigation focused on NO effects on INa
in the setting of an identified mutation in syntrophin that results
in one variant of a pattern of ventricular rhythm disturbances,
denoted the long Q-T syndrome (cf. Moss et al., 2008; Thomas
et al., 2008).
It has been proposed (Dallas et al., 2012) that considera-
tion should be given to utilization of ranolazine or ranolazine-
like compounds in clinical settings (Emergency or Critical
Care Medicine) that involve documented CO poisoning and
involve ventricular rhythm disturbances. Improved clinical inter-
ventions directed toward minimizing cardiac risk during the
required recovery period from CO intoxication are much needed
(Goldstein, 2008; Motterlini and Otterbein, 2010). In prin-
ciple, and as illustrated, ranolazine or ranolazine-like com-
pounds could be considered for this purpose (Belardinelli
et al., 2006; Kinobe et al., 2008; Saint, 2008; Wu et al., 2009).
Ranolazine quite selectively targets INa-L. However, the net cur-
rent change that is the direct result of ranolazine interaction
with Na+ channel, is integrated in the overall cardiac elec-
trophysiological system (biophysical mechanism) for mainte-
nance and generation of the plateau of the AP, in a way that
involves complex, often non-linear interactions of a number
of different currents (Fink et al., 2006). Thus, a monotonic
dose-response relationship for ranolazine effects is not antic-
ipated in this type of clinical/therapeutic setting/application
and individual differences in the electrophysiological sub-
strate are expected to/need to continue to be considered
(Sarkar et al., 2012).
The computations presented in this paper have all been carried
out assuming that the CO target is a single ventricular myocyte.
Although this is a valid starting point, it is known that the isolated
single human ventricular myocyte has electrophysiological char-
acteristics somewhat different than the samemyocyte functionally
joined to other myocytes through gap junction or “placed” in a
syncytium consisting of many other similar or identical myocytes.
Often, the AP waveform in the syncytium is slightly but sig-
nificantly different than that in a single cell. For example, the
plateau “height” is less depolarized in the syncytium. Intracellular
current flow, and other factors, such as intrinsic electrophysio-
logical heterogeneity of the myocytes, can also result in the AP
of a myocyte within a syncytium having a more stable resting
potential together with much less intrinsic action APD variabil-
ity (Huelsing et al., 2000; Zaniboni et al., 2000; Spitzer et al.,
2006). In addition, it is now known that in both the ventricu-
lar and the atrial myocardium the fibroblast/myofibroblast cell
population (Wu and Wang, 2005) may produce significant elec-
trotonic effects (Maleckar et al., 2009, cf. Baudino et al., 2006).
It is possible that either CO or its immediate downstream signal-
ing molecules could alter fibroblast electrophysiology/paracrine
function. One or more of these factors may alter the pattern of
response which we have observed in our in silico investigation of
CO effects.
LIMITATIONS
We are aware that as presented our analysis of CO effects on the
human ventricle is incomplete. Primary reasons for this include:
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1. The computational platform that we have used is comprehen-
sive and has been tested in terms of its ability to illustrate
the functional roles of many of the individual ion channel
currents that underlie the AP. However, it and most other
such models have limitations. In this paper, we illustrate
pronounced effects on APwaveforms and pro-arrhythmic pat-
terns of response that arise from very small current changes
that would be consistent with CO effects. The Grandi model
(Grandi et al., 2010) can be relied on as a computational
platform for human ventricular myocytes when exploring
problems that can be addressed with semi-quantitative end-
points. However, caution is warranted when the input data
suggests only e.g., a 1–3mV shift in an activation parameter
(cf. Terkildsen et al., 2008).
2. It is apparent that simulation of CO-mediated electrophysio-
logical effects requires detailed understanding of each major
component of Ca2+ homeostasis in the human ventricular
myocyte. Recent publications show that S-nitrosylation can
alter ryanodine receptor function and change Ca2+-induced
Ca2+ release (Ahern et al., 2000; Wang et al., 2010; Cutler
et al., 2012). Our work does not address this possibility.
In fact, in the Grandi et al. modeling environment (Grandi
et al., 2010) detailed studies of the consequences of changes
in Ca2+-induced Ca2+ release (CICR) are not possible since
many of the known subcellular details of CICR release are
not included in this computational platform. After this model
is developed further and e.g., the existing electrophysiologi-
cal components are integrated with known properties of E-C
coupling and mechanical activation (Tao et al., 2011), further
insights into CO-mediated effects may be able to be obtained
and Ca2+-pump (SERCA 2) mediated relaxation.
3. Detailed studies of CO-mediated alterations of mammalian
cardiac electrophysiological phenomena are relatively recent.
At present, there is incomplete information on clinically rele-
vant plasma levels, interspecies variations, and specific intra-
cellular signaling cascades. This information is essential for
more extensive simulations that could address cellular or
molecular mechanisms for CO-INa-NO interactions (Ueda
et al., 2008), including those arising from ion channel muta-
tions (Thomas et al., 2008) or changes in intercellular cou-
pling (Haas and Landisman, 2011), identification or selection
of therapeutic agents, and improvement of Systems Biology
(Winslow et al., 2011) approaches to human cardiac sudden
death in humans.
4. Our work is not intended to detract from or replace well-
established principles of CO generation or action (Maines,
1997) based on the heme oxygenase system. However, two
points are noteworthy. (i) It is now known that an essential site
of action of CO in resistance vessels is a reduced heme moiety
that is co-localized with the Ca2+-activated K+ channels that
modulate CO-induced vasodilation (Jaggar et al., 2005). (ii)
CO challenge results in compromised haemoglobin function
and pronounced hypoxia. Hypoxia is an established condi-
tion that results in augmented INa-L in the myocardium (Ju
et al., 1996). A recent paper advances an interesting plausi-
ble scenario in which micro-anatomical integration, that is
co-expression of Na+ channels, NO synthase isoform and G
proteins are co-localized in caveolae (Besse et al., 2011).
5. Our approach to the pro-arrhythmic effects of CO challenge
has placed an emphasis on EAD initiation. We acknowledge
that alterations in micro- or macroscopic conduction patterns
or velocities; and/or INa, INa-L, and ICa-L dependent changes
in AP waveform have not been ruled out as plausible pro-
arrhythmic elements. These, along with the S-nitosylation
induced change in mammalian heart K+ currents (Gómez
et al., 2009; Tamargo et al., 2010), could form the basis of
a more comprehensive study, after sufficient data from one
mammalian species, preferably human, is obtained.
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